CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development	$ 7,124	$ 9,841
General and administrative	5,104	5,002
Total operating expenses	12,228	14,843
Loss from operations	(12,228)	(14,843)
Change in fair value of convertible notes	0	15,890
Other income (expense), net	1,197	158
Total other income (expense), net	1,197	16,048
Income (loss) before provision for income taxes and loss from equity method investment	(11,031)	1,205
Provision for income taxes	0	0
Loss from equity method investment	0	(176)
Net loss	$ (11,031)	$ 1,029
Net loss per share - basic	$ (0.9)	$ 1.03
Net loss per share - diluted	$ (0.9)	$ (6.33)
Weighted-average common shares - basic	12,197,615	995,280
Weighted-average common shares - diluted	12,197,615	2,334,180